阿斯利康Gianluca Pirozzi博士:中国成全球罕见病研发“突破引擎” 高价值药物有望构建商业闭环

每日经济新闻
Sep 29

“作为一名医生,同时也是罕见病患儿的父亲,我深知这个群体面临双重困境,既难以确诊,又无药可治。”日前,阿斯利康全球高级副总裁Gianluca Pirozzi博士在接受《每日经济新闻》记者专访时如是袒露心声。  统计数据显示,目前已知罕见病超1万种,但90%缺乏有效治疗手段,80%为遗传性疾病且多在儿童期发病,平均诊断周期长达4.8年。这一严峻现状正在被全球医药巨头与中国市场深度绑定所改变。  ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10